Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice? - Wikidata - awgldk - TriplyDB

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

http://www.wikidata.org/entity/Q47124161

about

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

http://www.wikidata.org/entity/Q47124161

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

@en

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

@nl

type

label

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

@en

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

@nl

prefLabel

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

@en

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

@nl

P1433

Q47124161-8520B56E-78F4-4DB0-A488-4EEC38543A3C

P1476

Q47124161-6325F5F9-6E1C-4AF6-A063-729BD9B82FC5

P2093

Q47124161-EDBCA3FA-CF18-45D6-ABBB-D783DF17222E

P2860

Q47124161-095703B0-6388-4C24-9F7C-8056401697A0

Q47124161-0CC75D7D-ECBD-4FC9-8AFC-BB518B1D8E5D

Q47124161-2723C467-0074-4BAC-AFA2-0D35B1963217

Q47124161-295B0BE9-108B-46DB-B66A-B8ECB92F6F3E

Q47124161-3EA9D5CE-8248-412D-90F0-EB22ACF552B0

Q47124161-42253518-35F7-43A5-8DF5-9B133BA5C1F8

Q47124161-5F40CE05-C2D5-48EB-8DB7-7376348DC602

Q47124161-6418BFC1-533C-44BC-848F-8B1CF75835FB

Q47124161-7743E660-E3B6-43AE-93A8-72786FAD4DB6

Q47124161-83ED4878-9EEF-440E-88D9-700DA08AE666

P304

Q47124161-7CF5866D-C515-4897-816B-E6D4E486533D

P31

Q47124161-AB534F94-0314-4FC5-B385-59EE6342EE14

Q47124161-cd57e3a5-98f0-4a97-bbf5-dfce54be9995

P356

Q47124161-F79CF333-5F2D-42D7-817D-2046BDEEC772

P433

Q47124161-768CD965-7C35-4709-8137-CA3D7DBA688F

P478

Q47124161-91421498-66AF-4D69-8A8A-762DEB7A4244

P577

Q47124161-B2799FB3-D38A-4FFC-A48B-87371D3D7034

P698

Q47124161-EF78D5A8-DA2B-4EAE-80DB-CD6857A3491C

P932

Q47124161-D260B9BD-0C1F-4391-8A71-DA7B869F9B62

P356

P1433

Journal of thoracic disease

P1476

Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

@en

P2093

Chun-Yih Hsieh

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran versus warfarin in patients with atrial fibrillation

National Trends and Impact of Acute Kidney Injury Requiring Hemodialysis in Hospitalizations With Atrial Fibrillation

Acute kidney injury associates with increased long-term mortality

Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases.

The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients.

Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study.

Dabigatran-Related Nephropathy in a Patient with Undiagnosed IgA Nephropathy

Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Kidney function influences warfarin responsiveness and hemorrhagic complications.

P304

2852-2855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.08.94

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29221255

http://www.w3.org/2001/XMLSchema#string

P932

5708452

http://www.w3.org/2001/XMLSchema#string